Search Result "TKI"


Review Article

Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy

Journal: Current Drug Metabolism
Volume: 18 Issue: 3 Year: 2017 Page: 199-206
Author(s): Ruiqing Wang,Chaoqin Zhong,Chen Zhang,Mingqiang Hua,Daoxin Ma

Review Article

Understanding and Targeting the Epigenetic Regulation to Overcome EGFR-TKIs Resistance in Human Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 18 Issue: 0 Year: 2023 Page: 1-11
Author(s):

Current Frontiers

In vivo PET Imaging of EGFR Expression: An Overview of Radiolabeled EGFR TKIs

Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 28 Year: 2022 Page: 2329-2342
Author(s):

Research Article

Anti-Proliferative Role of the Tyrosine Kinase Inhibitors TKI-258 on Oral Squamous Cell Carcinoma In Vitro

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 6 Year: 2020 Page: 751-755
Author(s): Isadora C. Silveira,Anna Cecília D.M. Carneiro,Lorraine S. Hiss,Virgínia O. Crema

open access plus

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma

Journal: Current Drug Discovery Technologies
Volume: 13 Issue: 2 Year: 2016 Page: 68-76
Author(s): Akash Verma, Akhil Chopra, Yeo W. Lee, Lavina D. Bharwani, Atasha B. Asmat, Dokeu B.A Aneez, Fazuludeen A. Akbar, Albert Y.H. Lim, Sanjay H. Chotirmall, John Abisheganaden

Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9 Issue: 3 Year: 2014 Page: 382-393
Author(s): Suresh Kumar,Ritesh Agrawal

Review Article

Drug Combinatorial Therapies for the Treatment of KRAS Mutated Lung Cancers

Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2019 Page: 2128-2142
Author(s): Hao He,Chang Xu,Zhao Cheng,Xiaoying Qian,Lei Zheng

The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?

Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1284-1292
Author(s): Francesco Passiglia,Nele Van Der Steen,Luis Raez,Patrick Pauwels,Ignacio Gil-Bazo,Edgardo Santos,Daniele Santini,Giovanni Tesoriere,Antonio Russo,Giuseppe Bronte,Karen Zwaenepoel,Federico Cappuzzo,Christian Rolfo

Mini-Review Article

SHP2 Inhibition Benefits Epidermal Growth Factor Receptor-mutated Non-Small Cell Lung Cancer Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 21 Issue: 1 Year: 2021 Page: 1314-1321
Author(s): Leiming Xia,Lu Wen,Siying Wang

siRNA-Mediated Knock-Down of P-Glycoprotein Expression Reveals Distinct Cellular Disposition of Anticancer Tyrosine Kinases Inhibitors

Journal: Drug Metabolism Letters
Volume: 4 Issue: 2 Year: 2010 Page: 114-119
Author(s): Amina Haouala, Holger Rumpold, Gerold Untergasser, Thierry Buclin, Hans-Beat Ris, Nicolas Widmer, Laurent A. Decosterd

Previous   Next

Go To   Results 1 - 1 of 906

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy